Therapeutic Effects of Prebiotics on Constipation: A Schematic Review

Author(s): Maliha Naseer, Shiva Poola, Suleyman Uraz, Veysel Tahan*

Journal Name: Current Clinical Pharmacology
Continued as Current Reviews in Clinical and Experimental Pharmacology

Volume 15 , Issue 3 , 2020


Graphical Abstract:


Abstract:

Constipation is a highly prevalent functional gastrointestinal disorder that may significantly affect the quality of life and health care costs. Treatment for constipation has been broadly reviewed by cognitive therapies, medications, and surgical interventions. Gut microbiota such as Bifidobacterium, Clostridium, Bacteroidetes, and Lactobacilli have been demonstrated in functional gastrointestinal disorders and prebiotics to play a role in augmenting their presence. Prebiotics are ingredients in foods that remain undigested, stimulating the bacteria. There are a variety of prebiotics; however, there exists only a handful of studies that describe their efficacy for chronic constipation. The purpose of this study is to review the available literature on the utility of different commercially available prebiotics in patients with functional and chronic idiopathic constipation. To fulfil the objectives of the study, published articles in the English language on databases such as Pubmed, Ovid Medline, and EMBASE were searched. The terms prebiotics, constipation, chronic constipation, functional constipation were used. We reviewed and included 21 randomized controlled trials exploring the role of prebiotics in constipated adults. Prebiotics are effective treatments for chronic idiopathic constipation and showed improvement in the stool consistency, number of bowel moments and bloating. Although which prebiotic formulary would promote improved symptoms of constipation is still not clear.

Keywords: Prebiotic, idiopathic constipation, dysbiosis, galactan, fructan, gastrointestinal microbiome.

[1]
Suares NC, Ford AC. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: Systematic review and meta-analysis. Am J Gastroenterol 2011; 106(9): 1582-92.
[2]
Sanchez M I P, Bercik P. Epidemiology and burden of chronic constipationCan J Gastroenterol 2011; 25(B)11B-15B.
[3]
Bharucha AE, Pemberton JH, Locke GR III. American Gastroenterological Association technical review on constipation. Gastroenterology 2013; 144(1): 218-38.
[http://dx.doi.org/10.1053/j.gastro.2012.10.028] [PMID: 23261065]
[4]
Nuyts G, Dubois D, Jones M, Talley N. Risk factors for chronic constipation: A case-control study in a large general practice population. Gastroenterology 2000; 118(4): A693.
[http://dx.doi.org/10.1016/S0016-5085(00)84906-9]
[5]
Shin A, Preidis GA, Shulman R, Kashyap PC. The gut microbiome in adult and pediatric functional gastrointestinal disorders. Clin Gastroenterol Hepatol 2019; 17(2): 256-74.
[http://dx.doi.org/10.1016/j.cgh.2018.08.054] [PMID: 30153517]
[6]
Roager HM, Hansen LBS, Bahl MI, et al. Colonic transit time is related to bacterial metabolism and mucosal turnover in the gut. Nat Microbiol 2016; 1(9): 16093-9.
[http://dx.doi.org/10.1038/nmicrobiol.2016.93] [PMID: 27562254]
[7]
Vandeputte D, Falony G, Vieira-Silva S, Tito RY, Joossens M, Raes J. Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut 2016; 65(1): 57-62.
[http://dx.doi.org/10.1136/gutjnl-2015-309618] [PMID: 26069274]
[8]
Lu PL, Mousa HM. Constipation: Beyond the old paradigms. Gastroenterol Clin North Am 2018; 47(4): 845-62.
[http://dx.doi.org/10.1016/j.gtc.2018.07.009] [PMID: 30337036]
[9]
Hayat U, Dugum M, Garg S. Chronic constipation: Update on management. Cleve Clin J Med 2017; 84(5): 397-408.
[http://dx.doi.org/10.3949/ccjm.84a.15141] [PMID: 28530898]
[10]
Moayyedi P, Ford AC, Talley NJ, et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: A systematic review. Gut 2010; 59(3): 325-32.
[http://dx.doi.org/10.1136/gut.2008.167270] [PMID: 19091823]
[11]
Probiotics in Food. Health and Nutritional Properties and Guidelines for Evaluation. Rome: Food and Agriculture Organization of the United Nations World Health Organization 2006.
[12]
Verdú EF, Bercik P, Verma-Gandhu M, et al. Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut 2006; 55(2): 182-90.
[http://dx.doi.org/10.1136/gut.2005.066100] [PMID: 16105890]
[13]
Ford AC, Quigley EMM, Lacy BE, et al. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: Systematic review and meta-analysis. Am J Gastroenterol 2014; 109(10): 1547-61.
[14]
Yu T, Zheng Y-P, Tan J-C, Xiong W-J, Wang Y, Lin L. Effects of prebiotics and synbiotics on functional constipation. Am J Med Sci 2017; 353(3): 282-92.
[http://dx.doi.org/10.1016/j.amjms.2016.09.014] [PMID: 28262216]
[15]
Parthasarathy G, Chen J, Chen X, et al. Relationship between microbiota of the colonic mucosa vs. feces and symptoms, colonic transit, and methane production in female Patients with chronic constipation. Gastroenterology 2016; 150(2): 367-79.
[http://dx.doi.org/10.1053/j.gastro.2015.10.005] [PMID: 26460205]
[16]
Attaluri A, Jackson M, Valestin J, Rao SSC. Methanogenic flora is associated with altered colonic transit but not stool characteristics in constipation without IBS. Am J Gastroenterol 2010; 105(6): 1407-11.
[http://dx.doi.org/10.1038/ajg.2009.655] [PMID: 19953090]
[17]
Sia TC, Flack N, Robinson L, et al. Is serotonin in enteric nerves required for distension-evoked peristalsis and propulsion of content in guinea-pig distal colon? Neuroscience 2013; 240: 325-35.
[http://dx.doi.org/10.1016/j.neuroscience.2013.02.061] [PMID: 23500097]
[18]
Belizário JE, Faintuch J. Microbiome and gut dysbiosis. Exp Suppl 2018; 109(6): 459-76.
[http://dx.doi.org/10.1007/978-3-319-74932-7_13] [PMID: 30535609]
[19]
Yu Y, Mao G, Wang J, et al. Gut dysbiosis is associated with the reduced exercise capacity of elderly patients with hypertension. Hypertens Res 2018; 41(12): 1036-44.
[http://dx.doi.org/10.1038/s41440-018-0110-9] [PMID: 30291307]
[20]
Hillman ET, Lu H, Yao T, Nakatsu CH. Microbial ecology along the gastrointestinal tract. Microbes Environ 2017; 32(4): 300-13.
[http://dx.doi.org/10.1264/jsme2.ME17017] [PMID: 29129876]
[21]
Jandhyala SM, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, Nageshwar Reddy D. Role of the normal gut microbiota. World J Gastroenterol 2015; 21(29): 8787-803.
[http://dx.doi.org/10.3748/wjg.v21.i29.8787] [PMID: 26269668]
[22]
Tuddenham S, Sears CL. The intestinal microbiome and health. Curr Opin Infect Dis 2015; 28(5): 464-70.
[http://dx.doi.org/10.1097/QCO.0000000000000196] [PMID: 26237547]
[23]
Zoppi G, Cinquetti M, Luciano A, Benini A, Muner A, Bertazzoni Minelli E. The intestinal ecosystem in chronic functional constipation. Acta Paediatr 1998; 87(8): 836-41.
[http://dx.doi.org/10.1111/j.1651-2227.1998.tb01547.x] [PMID: 9736230]
[24]
Zhu L, Liu W, Alkhouri R, et al. Structural changes in the gut microbiome of constipated patients. Physiol Genomics 2014; 46(18): 679-86.
[http://dx.doi.org/10.1152/physiolgenomics.00082.2014] [PMID: 25073603]
[25]
de Meij TGJ, de Groot EFJ, Eck A, et al. Characterization of microbiota in children with chronic functional constipation. PLoS One 2016; 11(10)e0164731
[http://dx.doi.org/10.1371/journal.pone.0164731] [PMID: 27760208]
[26]
Khalif IL, Quigley EMM, Konovitch EA, Maximova ID. Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation. Dig Liver Dis 2005; 37(11): 838-49.
[http://dx.doi.org/10.1016/j.dld.2005.06.008] [PMID: 16169298]
[27]
Kim S-E, Choi SC, Park KS, et al. Change of fecal flora and effectiveness of the short-term VSL#3 probiotic treatment in patients with functional constipation. J Neurogastroenterol Motil 2015; 21(1): 111-20.
[http://dx.doi.org/10.5056/jnm14048] [PMID: 25537674]
[28]
Cao H, Liu X, An Y, et al. Dysbiosis contributes to chronic constipation development via regulation of serotonin transporter in the intestine. Sci Rep 2017; 7(1): 10322-2.
[http://dx.doi.org/10.1038/s41598-017-10835-8] [PMID: 28871143]
[29]
Reigstad CS, Salmonson CE, Rainey JF III, et al. Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells. FASEB J 2015; 29(4): 1395-403.
[http://dx.doi.org/10.1096/fj.14-259598] [PMID: 25550456]
[30]
Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. J Nutr 1995; 125(6): 1401-12.
[http://dx.doi.org/10.1093/jn/125.6.1401] [PMID: 7782892]
[31]
Hill C, Guarner F, Reid G, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014; 11(8): 506-14.
[http://dx.doi.org/10.1038/nrgastro.2014.66] [PMID: 24912386]
[32]
Ohkusa T, Koido S, Nishikawa Y, Sato N. Gut microbiota and chronic constipation: A review and update. Front Med (Lausanne) 2019; 6: 19.
[http://dx.doi.org/10.3389/fmed.2019.00019] [PMID: 30809523]
[33]
Louis P, Flint HJ, Michel C. How to manipulate the microbiota: Prebiotics. Adv Exp Med Biol 2016; 902(1): 119-42.
[http://dx.doi.org/10.1007/978-3-319-31248-4_9] [PMID: 27161355]
[34]
Davani-Davari D, Negahdaripour M, Karimzadeh I, et al. Prebiotics: Definition, types, sources, mechanisms, and clinical applications. Foods 2019; 8(3): 92.
[http://dx.doi.org/10.3390/foods8030092] [PMID: 30857316]
[35]
Rabiu BA, Jay AJ, Gibson GR, Rastall RA. Synthesis and fermentation properties of novel galacto-oligosaccharides by beta-galactosidases from Bifidobacterium species. Appl Environ Microbiol 2001; 67(6): 2526-30.
[http://dx.doi.org/10.1128/AEM.67.6.2526-2530.2001] [PMID: 11375159]
[36]
Esgalhado M, Kemp JA, Damasceno NR, Fouque D, Mafra D. Short-chain fatty acids: A link between prebiotics and microbiota in chronic kidney disease. Future Microbiol 2017; 12(15): 1413-25.
[http://dx.doi.org/10.2217/fmb-2017-0059] [PMID: 29027814]
[37]
McLoughlin RF, Berthon BS, Jensen ME, Baines KJ, Wood LG. Short-chain fatty acids, prebiotics, synbiotics, and systemic inflammation: A systematic review and meta-analysis. Am J Clin Nutr 2017; 106(3): 930-45.
[http://dx.doi.org/10.3945/ajcn.117.156265] [PMID: 28793992]
[38]
Sitanggang AB, Drews A, Kraume M. Recent advances on prebiotic lactulose production. World J Microbiol Biotechnol 2016; 32(9): 154.
[http://dx.doi.org/10.1007/s11274-016-2103-7] [PMID: 27465854]
[39]
Wang H, Yang R, Hua X, Zhao W, Zhang W. Enzymatic production of lactulose and 1-lactulose: Current state and perspectives. Appl Microbiol Biotechnol 2013; 97(14): 6167-80.
[http://dx.doi.org/10.1007/s00253-013-4998-3] [PMID: 23775268]
[40]
Bouhnik Y, Attar A, Joly FA, Riottot M, Dyard F, Flourié B. Lactulose ingestion increases faecal bifidobacterial counts: A randomised double-blind study in healthy humans. Eur J Clin Nutr 2004; 58(3): 462-6.
[http://dx.doi.org/10.1038/sj.ejcn.1601829] [PMID: 14985684]
[41]
Sakai Y, Seki N, Hamano H, et al. A study of the prebiotic effect of lactulose at low dosages in healthy Japanese women. Biosci Microbiota Food Health 2019; 38(2): 69-72.
[http://dx.doi.org/10.12938/bmfh.18-013] [PMID: 31106110]
[42]
Bouhnik Y, Neut C, Raskine L, et al. Prospective, randomized, parallel-group trial to evaluate the effects of lactulose and polyethylene glycol-4000 on colonic flora in chronic idiopathic constipation. Aliment Pharmacol Ther 2004; 19(8): 889-99.
[http://dx.doi.org/10.1111/j.1365-2036.2004.01918.x] [PMID: 15080850]
[43]
Sanders JF. Lactulose syrup assessed in a double-blind study of elderly constipated patients. J Am Geriatr Soc 1978; 26(5): 236-9.
[http://dx.doi.org/10.1111/j.1532-5415.1978.tb01967.x] [PMID: 346631]
[44]
Zhou X, Ruan Z, Huang X, Zhou Y, Liu S, Yin Y. The prebiotic lactosucrose modulates gut metabolites and microbiota in intestinal inflammatory rats. Food Sci Biotechnol 2013; 23(1): 157-63.
[http://dx.doi.org/10.1007/s10068-014-0021-8]
[45]
Scheppach W. Effects of short chain fatty acids on gut morphology and function. Gut 1994; 35(1)(Suppl.): S35-8.
[http://dx.doi.org/10.1136/gut.35.1_Suppl.S35] [PMID: 8125387]
[46]
Teramoto F, Rokutan K, Kawakami Y, et al. Effect of 4G-beta-D-galactosylsucrose (lactosucrose) on fecal microflora in patients with chronic inflammatory bowel disease. J Gastroenterol 1996; 31(1): 33-9.
[http://dx.doi.org/10.1007/BF01211184] [PMID: 8808426]
[47]
Hashimoto MF, Fujii C, Matsuo K, et al. Effects of administration of 4G-B-D-Galactosylsucrose on fecal microflora, putrefactive products, short-chain fatty acids, weight, moisture and pH, and subjective sensation of defecation in the elderly with constipation. J Clin Biochem Nutr 1992; 13(3): 199-210.
[http://dx.doi.org/10.3164/jcbn.13.199]
[48]
Terada A, Hara H, Sakamoto J, et al. Effects of dietary supplementation with lactosucrose (4G-beta-D-galactosylsucrose) on cecal flora, cecal metabolites, and performance in broiler chickens. Poult Sci 1994; 73(11): 1663-72.
[http://dx.doi.org/10.3382/ps.0731663] [PMID: 7862605]
[49]
Niness KR. Inulin and oligofructose: What are they? J Nutr 1999; 129(7)(Suppl.): 1402S-6S.
[http://dx.doi.org/10.1093/jn/129.7.1402S] [PMID: 10395607]
[50]
Flamm G, Glinsmann W, Kritchevsky D, Prosky L, Roberfroid M. Inulin and oligofructose as dietary fiber: A review of the evidence. Crit Rev Food Sci Nutr 2001; 41(5): 353-62.
[http://dx.doi.org/10.1080/20014091091841] [PMID: 11497328]
[51]
Gibson GR, Beatty ER, Wang X, Cummings JH. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 1995; 108(4): 975-82.
[http://dx.doi.org/10.1016/0016-5085(95)90192-2] [PMID: 7698613]
[52]
Kolida S, Tuohy K, Gibson GR. Prebiotic effects of inulin and oligofructose. Br J Nutr 2002; 87(2): S193-7.
[http://dx.doi.org/10.1079/BJN/2002537]
[53]
Buddington RK, Kapadia C, Neumer F, Theis S. Oligofructose provides laxation for irregularity associated with low fiber intake. Nutrients 2017; 9(12): 1372.
[http://dx.doi.org/10.3390/nu9121372] [PMID: 29258261]
[54]
Linetzky WD, Alves PCC, Logullo L, et al. Microbiota benefits after inulin and partially hydrolized guar gum supplementation: A randomized clinical trial in constipated women. Nutr Hosp 2012; 27(1): 123-9.
[PMID: 22566311]
[55]
Marteau P, Jacobs H, Cazaubiel M, Signoret C, Prevel J-M, Housez B. Effects of chicory inulin in constipated elderly people: A double-blind controlled trial. Int J Food Sci Nutr 2011; 62(2): 164-70.
[http://dx.doi.org/10.3109/09637486.2010.527323] [PMID: 21091293]
[56]
Vandeputte D, Falony G, Vieira-Silva S, et al. Prebiotic inulin-type fructans induce specific changes in the human gut microbiota. Gut 2017; 66(11): 1968-74.
[http://dx.doi.org/10.1136/gutjnl-2016-313271] [PMID: 28213610]
[57]
Micka A, Siepelmeyer A, Holz A, Theis S, Schön C. Effect of consumption of chicory inulin on bowel function in healthy subjects with constipation: A randomized, double-blind, placebo-controlled trial. Int J Food Sci Nutr 2017; 68(1): 82-9.
[http://dx.doi.org/10.1080/09637486.2016.1212819] [PMID: 27492975]
[58]
Jalanka J, Major G, Murray K, et al. The effect of Psyllium husk on intestinal microbiota in constipated patients and healthy controls. Int J Mol Sci 2019; 20(2): 433.
[http://dx.doi.org/10.3390/ijms20020433] [PMID: 30669509]
[59]
Erdogan A, Rao SSC, Thiruvaiyaru D, et al. Randomised clinical trial: Mixed soluble/insoluble fibre vs. psyllium for chronic constipation. Aliment Pharmacol Ther 2016; 44(1): 35-44.
[http://dx.doi.org/10.1111/apt.13647] [PMID: 27125883]
[60]
Garg P. Psyllium husk should be taken at higher dose with sufficient water to maximize its efficacy. J Acad Nutr Diet 2017; 117(5): 681.
[http://dx.doi.org/10.1016/j.jand.2017.03.001] [PMID: 28449791]
[61]
Elli M, Cattivelli D, Soldi S, Bonatti M, Morelli L. Evaluation of prebiotic potential of refined psyllium (Plantago ovata) fiber in healthy women. J Clin Gastroenterol 2008; 42(Suppl. 3 Pt 2): S174-6.
[http://dx.doi.org/10.1097/MCG.0b013e31817f183a] [PMID: 18685505]
[62]
McRorie JW, Daggy BP, Morel JG, Diersing PS, Miner PB, Robinson M. Psyllium is superior to docusate sodium for treatment of chronic constipation. Aliment Pharmacol Ther 1998; 12(5): 491-7.
[http://dx.doi.org/10.1046/j.1365-2036.1998.00336.x] [PMID: 9663731]
[63]
Noureddin S, Mohsen J, Payman A. Effects of psyllium vs. placebo on constipation, weight, glycemia, and lipids: A randomized trial in patients with type 2 diabetes and chronic constipation. Complement Ther Med 2018; 40: 1-7.
[http://dx.doi.org/10.1016/j.ctim.2018.07.004] [PMID: 30219432]
[64]
Kanauchi O, Andoh A, Iwanaga T, et al. Germinated barley foodstuffs attenuate colonic mucosal damage and mucosal nuclear factor kappa B activity in a spontaneous colitis model. J Gastroenterol Hepatol 1999; 14(12): 1173-9.
[http://dx.doi.org/10.1046/j.1440-1746.1999.02025.x] [PMID: 10634153]
[65]
Kanauchi O, Fujiyama Y, Mitsuyama K, et al. Increased growth of Bifidobacterium and Eubacterium by germinated barley foodstuff, accompanied by enhanced butyrate production in healthy volunteers. Int J Mol Med 1999; 3(2): 175-9.
[http://dx.doi.org/10.3892/ijmm.3.2.175] [PMID: 9917526]
[66]
Araki Y, Andoh A, Koyama S, Fujiyama Y, Kanauchi O, Bamba T. Effects of germinated barley foodstuff on microflora and short chain fatty acid production in dextran sulfate sodium-induced colitis in rats. Biosci Biotechnol Biochem 2000; 64(9): 1794-800.
[http://dx.doi.org/10.1271/bbb.64.1794] [PMID: 11055379]
[67]
Yanahira S, Yabe Y, Nakakoshi M, Miura S, Matsubara N, Ishikawa H. Structures of novel acidic galactooligosaccharides synthesized by Bacillus circulans beta-galactosidase. Biosci Biotechnol Biochem 1998; 62(9): 1791-4.
[http://dx.doi.org/10.1271/bbb.62.1791] [PMID: 9805383]
[68]
Niittynen L, Kajander K, Korpela R. Galacto-Oligosaccharides and Bowel Function. Scandinavian. J Food Nutr 2016; 51(2): 62-6.
[http://dx.doi.org/10.1080/17482970701414596]
[69]
Grimaldi R, Swann JR, Vulevic J, Gibson GR, Costabile A. Fermentation properties and potential prebiotic activity of Bimuno® galacto-oligosaccharide (65% galacto-oligosaccharide content) on in vitro gut microbiota parameters. Br J Nutr 2016; 116(3): 480-6.
[http://dx.doi.org/10.1017/S0007114516002269] [PMID: 27267934]
[70]
Walton GE, van den Heuvel EGHM, Kosters MHW, Rastall RA, Tuohy KM, Gibson GR. A randomised crossover study investigating the effects of galacto-oligosaccharides on the Faecal microbiota in men and women over 50 years of age. Br J Nutr 2012; 107(10): 1466-75.
[http://dx.doi.org/10.1017/S0007114511004697] [PMID: 21910949]
[71]
Vulevic J, Drakoularakou A, Yaqoob P, Tzortzis G, Gibson GR. Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers. Am J Clin Nutr 2008; 88(5): 1438-46.
[PMID: 18996881]
[72]
Thomson P, Medina DA, Garrido D. Human milk oligosaccharides and infant gut bifidobacteria: Molecular strategies for their utilization. Food Microbiol 2018; 75: 37-46.
[http://dx.doi.org/10.1016/j.fm.2017.09.001] [PMID: 30056961]
[73]
Teuri U, Korpela R. Galacto-oligosaccharides relieve constipation in elderly people. Ann Nutr Metab 1998; 42(6): 319-27.
[http://dx.doi.org/10.1159/000012751] [PMID: 9895419]
[74]
Sairanen U, Piirainen L, Nevala R, Korpela R. Yoghurt containing galacto-oligosaccharides, prunes and linseed reduces the severity of mild constipation in elderly subjects. Eur J Clin Nutr 2007; 61(12): 1423-8.
[http://dx.doi.org/10.1038/sj.ejcn.1602670] [PMID: 17299467]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 15
ISSUE: 3
Year: 2020
Page: [207 - 215]
Pages: 9
DOI: 10.2174/1574884715666200212125035
Price: $65

Article Metrics

PDF: 46
HTML: 2